Search Results 1311-1320 of 15404 for Hepatitis b

  1. Meet The Faculty - Gastroenterology, Inflammatory Bowel Disease Fellowship (Florida) - Mayo Clinic College of Medicine & Science

    Hepatitis B vaccination efficacy in IBD patients; Subclinical hepatic fibrosis. View full profileOpens in new tab. Jana Al-Hashash ...

  2. Atezolizumab With Or Without Cobimetinib In Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery Or Gallbladder Cancer - Mayo Clinic

    ... hepatitis; cirrhosis; fatty liver; and inherited liver disease: Patients with past or resolved hepatitis B infection (defined as having a negative hepatitis B ...

  3. Gastroenterology and Hepatology - Doctors - Mayo Clinic

    ... Hepatitis C, Hepatitis B, Hepatocel...lular carcinoma, Nonalcoholic fatty liver disease, Cirrhosis, Autoimmune hepatitis, Alcoholic hepatitis, Hepatic ...

  4. Gastroenterology and Hepatology - Doctors - Mayo Clinic

    ... Hepatitis C, Hepatitis B, Nonalcoholic fatty liver disease..., Ascites, Portal hypertension, Alcoholic hepatitis. Show more areas of focus for Hugo E. Vargas ...

  5. A Study To Evaluate The Safety And Effectiveness Of BIIB054 In Subjects With Parkinson’s Disease - Mayo Clinic

    Current hepatitis B infection (defined as positive for hepatitis B surface antigen [HBsAg] and/or total hepatitis B core antibody [anti-HBc]). Subjects with ...

  6. Proton SFRT V. SBRT For Borderline Unresectable/oligometastatic/recurrent Oral Cavity Cancer - Mayo Clinic

    Active infection including tuberculosis, hepatitis B (known positive HBV surface antigen [HBsAg] result), hepatitis C, or human immunodeficiency virus (positive ...

  7. Gastroenterology and Hepatology - Doctors - Mayo Clinic

    lar carcinoma, Cirrhosis, Hepatitis C, Hepatitis B, Nonalcoholic fatty liver disease, Autoimmune hepatitis, Alcoholic hepatitis, Fatty liver disease. Show ...

  8. ALSENLITE: Senolytics for Alzheimer's Disease - Mayo Clinic

    Known active hepatitis B or C infection 20. Invasive fungal or viral infection (as per clinical judgment) 21. Known hypersensitivity or allergy to D or Q 22 ...

  9. A Study To Determine Dose, Safety, And Efficacy Of Durvalumab As Monotherapy And In Combination Therapy In Subjects With Lymphoma Or Chronic Lymphocytic Leukemia - Mayo Clinic

    Subject who is seropositive for or active viral infection with hepatitis B virus (HBV) (hepatitis B surface antigen [HBsAg] positive and/or detectable viral DNA) ...

  10. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

    Participants who are hepatitis B surface antigen negative but are hepatitis B core antibody positive must have undetectable hepatitis B DNA and receive ...